Abstract:Recent research increasingly validates the early dissemination of tumor cells in peripheral blood during the nascent stages of cancer, often preceding clinical identification of the primary tumor. This emerging evidence emphasizes the potential of Circulating Tumor Cells (CTCs) as early indicators for cancer. Despite their significance, CTCs are exceptionally rare compared to normal blood cells, which presents a considerable challenge in detection, particularly during early stages of cancer. Traditional detection methods, such as those based on nucleated cell enrichment, antibody labeling and fluorescence imaging, encounter notable limitations when applied in the context of early detection. These limitations arise from the inherent heterogeneity of CTCs, and the multistep process involved in labeling and manual enumeration, compromising cell viability and resulting in cell loss. This loss becomes particularly problematic in the context of early cancer detection scenarios where the tumor burden is extremely low, and any cell loss can significantly impact assay sensitivity. To overcome these challenges, we propose an innovative CTC detection approach employing a deep learning framework combined with holographic imaging. This technique utilizes coherent light to generate holograms from cell samples, capturing detailed 3D morphological and optical properties of individual cells. We developed a custom convolutional neural network designed to facilitate high-throughput cell sorting in real-time. Trained on healthy blood samples and diverse cancer cell lines, the dataset consists of more than 50 million cellular holograms enhanced by proprietary Gaussian annotation and image augmentation strategies. Moreover, by combining the morphological signatures from holography with antigen signatures (e.g. HER2/ER/PR) in real-time, our model demonstrates the ability to detect less than 1 false positive per 1 million nucleated cells, highlighting its potential as a robust tool for targeted early-stage breast cancer detection. Our technology represents highly sensitive alternative to traditional screening methods, with the promise of enhancing patient outcomes. Citation Format: Nicholas Heller, Kevin Mallery, Nathaniel Bristow, Yash Travadi, Eng Hock Lee, Jiarong Hong. Detection of early-disseminated cancer cells with deep learning-enabled holographic imaging [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 2304.

Automated classification of elliptical cancer cells with stain-free holographic imaging and self-supervised learning

Machine-learning-mediated single-cell classification by hyperspectral stimulated Raman scattering imaging

Classification of unlabeled cells using lensless digital holographic images and deep neural networks

Real-time stain-free classification of cancer cells and blood cells using interferometric phase microscopy and machine learning

Learning deep features for dead and living breast cancer cell classification without staining

Computational Imaging Of Label-Free Cells Using Lens-Less Digital Holography

A Miniaturized and Intelligent Lensless Holographic Imaging System With Auto-Focusing and Deep Learning-Based Object Detection for Label-Free Cell Classification

Abstract 2304: Detection of early-disseminated cancer cells with deep learning-enabled holographic imaging

Weakly supervised identification of microscopic human breast cancer-related optical signatures from normal-appearing breast tissue

Microscopic medical image classification framework via deep learning and shearlet transform

Label-free cell classification in holographic flow cytometry through an unbiased learning strategy

Self-supervised learning for skin cancer diagnosis with limited training data

Colorectal cancer diagnosis from histology images: A comparative study

A combined microfluidic deep learning approach for lung cancer cell high throughput screening toward automatic cancer screening applications

DeepSMILE: Contrastive self-supervised pre-training benefits MSI and HRD classification directly from H&E whole-slide images in colorectal and breast cancer

Revealing 3D cancer tissue structures using holotomography and virtual hematoxylin and eosin staining via deep learning

Stain-free approach to determine and monitor cell heath using supervised and unsupervised image-based deep learning

Self-Supervised Deep Learning to Enhance Breast Cancer Detection on Screening Mammography

Enhancing breast cancer classification via histopathological image analysis: Leveraging self-supervised contrastive learning and transfer learning

Molecular Classification of Breast Cancer Using Weakly Supervised Learning